Skip to main content

Month: September 2020

SNOCKS Doubles Fulfillment Productivity with Descartes Ecommerce Warehouse Management Solution

MUNICH, Germany, Sept. 14, 2020 (GLOBE NEWSWIRE) — Descartes Systems Group (Nasdaq: DSGX) (TSX: DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that Germany’s SNOCKS, a lifestyle brand offering premium sneaker socks, clothes and accessories, has doubled its ecommerce fulfillment productivity and scaled for peak promotions using the Descartes Ecommerce Warehouse Management Solution (WMS).“The decision to augment our Amazon channel by launching SNOCKS, based on Shopify Plus, and take fulfillment into our own hands provides us with more control over the customer experience and shipping performance,” said Felix Bauer, founder of SNOCKS. “We worked closely with Descartes to build an efficient, technology-driven ecommerce warehouse and, in just two months, the solution was live. Since then, fulfillment...

Continue reading

Vista Gold Corp. Provides Update on the Mt Todd Gold Project and Highlights Strategic Growth Opportunities

DENVER, Sept. 14, 2020 (GLOBE NEWSWIRE) — Vista Gold Corp. (NYSE American and TSX: VGZ) (“Vista” or the “Company”) is pleased to provide an update on the Company’s 100% owned Mt Todd gold project (“Mt Todd” or the “Project”) located in Northern Territory, Australia and outline strategic growth opportunities.Key HighlightsVista continues to advance programs expected to add value and de-risk Mt Todd. Recent and ongoing programs include:A drill program to test Batman North extensions, with the goal of adding higher-grade, near surface mineral resources immediately adjacent to the planned Batman pitGeotechnical drilling and foundation investigations to shorten the time required to complete a feasibility study and support future detailed engineeringOngoing internal evaluations to assess the potential to increase recovered gold resources...

Continue reading

Comstock Mining Completes Lucerne Transaction; Recognizes an $18 million Gain on Sale

VIRGINIA CITY, Nev., Sept. 14, 2020 (GLOBE NEWSWIRE) — Comstock Mining Inc. (the “Company” or “Comstock”) (NYSE American: LODE) announced today that it has completed the sale of its Lucerne mine to Tonogold Resources, Inc. (“Tonogold”) for total value and consideration of approximately $25.9 million. The consideration includes $7.1 million in cash, $6.1 million in Convertible Preferred Stock (“CPS”), and a $4.475 million, 12% notes receivable, due and payable on September 20, 2021, plus the assumption of $6.7 million in future lease and reclamation obligations, that together represent a permanent reduction of annual operating expenses of approximately $1 million. The CPS had an initial recorded fair value of $7.6 million (and a higher fair value of $10.4 million at June 30, 2020). Comstock retained a 1.5% net smelter return (NSR)...

Continue reading

LexinFintech Holdings Ltd. to Provide Business Update on September 16, 2020

SHENZHEN, China, Sept. 14, 2020 (GLOBE NEWSWIRE) — LexinFintech Holdings Ltd. (“Lexin” or the “Company”) (NASDAQ: LX), a leading online consumption and consumer finance platform for new generation consumers in China, today announced that it will host a business update call at 5:00 AM U.S. Eastern time on September 16, 2020 (5:00 PM Beijing/Hong Kong time on September 16, 2020).Participants who wish to join the conference call should register online at:http://apac.directeventreg.com/registration/event/3777794Please note the Conference ID number of 3777794.Once registration is completed, participants will receive the dial-in information for the conference call, an event passcode, and a unique registrant ID number.Participants joining the conference call should dial-in at least 10 minutes before the scheduled...

Continue reading

HL Acquisitions Corp provides update on Business Combination with Fusion Fuel Green Ltd.

New York, NY, Sept. 14, 2020 (GLOBE NEWSWIRE) — HL Acquisitions Corp. (“HL”, NASDAQ: HCCH, HCCHU, HCCHR, HCCHW) announced today that it has mailed a proxy statement for a shareholder meeting to be held on October 2nd, 2020 at which time shareholders will be asked to approve an extension of the time it has to complete an initial business combination from October 2nd, 2020 to January 2nd, 2021.Commenting on the extension proposal, Jeffrey Schwarz, HL’s CEO said, “While we are disappointed that we will be unable to close our business combination with Fusion Fuel prior to October 2nd, we are pleased with the progress that has been made on the deal front. We recently received comments from the Securities and Exchange Commission on the proxy/registration statement that was filed on August 12th, and intend to refile the proxy/registration...

Continue reading

European Medicines Agency (EMA) approves safety label update for Novartis Beovu®

Novartis worked with the EMA to update the Beovu® (brolucizumab) label to guide physicians in their treatment of wet AMD   The update includes the additional characterization of retinal vasculitis and/or retinal vascular occlusion, typically in the presence of intraocular inflammation1 Novartis has established a multidisciplinary panel of internal experts collaborating with external advisors to examine the root cause, potential risk factors and mitigation of these adverse events Novartis is confident that Beovu continues to represent an important treatment option for patients with wet AMD, with an overall favorable benefit/risk profile Basel, September 14, 2020 — Novartis announced today that the Committee for Medicinal Products for Human Use (CHMP), has approved an update to the Beovu® (brolucizumab) Summary of Product Characteristics...

Continue reading

SpringWorks Therapeutics Announces Clinical Collaboration with Janssen to Evaluate Nirogacestat in Combination with Teclistamab in Patients with Relapsed or Refractory Multiple Myeloma

STAMFORD, Conn., Sept. 14, 2020 (GLOBE NEWSWIRE) — SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, today announced that the company has entered into a clinical collaboration and supply agreement with Janssen Biotech, Inc. (Janssen) to evaluate SpringWorks Therapeutics’ investigational gamma secretase inhibitor (GSI), nirogacestat, in combination with Janssen’s bispecific antibody targeting B-cell maturation antigen (BCMA) and CD3, teclistamab, in patients with relapsed or refractory multiple myeloma.Gamma secretase inhibition prevents the cleavage and shedding of BCMA from the surface of myeloma cells. In preclinical models, nirogacestat has been shown to increase the cell surface density of...

Continue reading

First Horizon Announces ClearPath Fast Payments Platform in Partnership with Interchecks

MEMPHIS, Tenn., Sept. 14, 2020 (GLOBE NEWSWIRE) — First Horizon National Corp. (NYSE:FHN) announced today that it will be launching ClearPath Fast Payments in partnership with Interchecks, an emerging fintech leader. This partnership will provide an innovative platform that delivers immediate payments capability to treasury management clients, making fast and convenient payments more accessible to businesses.“Following our merger with IBERIABANK, we are able to bring this industry-leading payment innovation to a broader market and better serve our clients,” said Somesh Kasibhatla, Head of Treasury Product Management.  “Whether receiving wages, commission payouts, insurance claim payments, or an incentive for renewing with your utility service, businesses and consumers want to be paid as quickly and conveniently as possible. Leveraging...

Continue reading

Atea Pharmaceuticals Appoints Polly Murphy, D.V.M, Ph.D., to the Board of Directors

BOSTON, Sept. 14, 2020 (GLOBE NEWSWIRE) — Atea Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of next-generation therapeutics for severe viral infections, today announced the appointment of Polly Murphy, D.V.M., Ph.D., Chief Business Officer of UroGen Pharma, to its Board of Directors. Dr. Murphy is a seasoned pharmaceutical executive with a wide range of experience spanning research and development, strategy and operations.“We are thrilled to welcome Dr. Murphy to Atea’s Board of Directors as her expertise and leadership in clinical, business and commercial development will be invaluable as we continue to advance our pipeline of antiviral product candidates. Her insight and guidance will be particularly beneficial as we accelerate the development of AT-527 as an oral treatment for patients...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.